A5087174023- Pharmaceutical Practices and Patient Outcomes
- Medication Adherence and Compliance
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Economic and Financial Impacts of Cancer
- Patient Satisfaction in Healthcare
- Pharmaceutical studies and practices
- Cancer survivorship and care
- Primary Care and Health Outcomes
- Antibiotic Use and Resistance
- Blood Pressure and Hypertension Studies
- Global Health Workforce Issues
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Telemedicine and Telehealth Implementation
- Diabetes Treatment and Management
- Healthcare Policy and Management
- Diabetes Management and Research
- Mobile Health and mHealth Applications
- Non-Invasive Vital Sign Monitoring
- Innovations in Medical Education
- Global Health and Surgery
- Opioid Use Disorder Treatment
- Health Sciences Research and Education
- Biosimilars and Bioanalytical Methods
- Historical Medical Research and Treatments
Five Prime Therapeutics (United States)
2022-2024
University of North Carolina at Chapel Hill
2017-2024
University of North Carolina Health Care
2018-2021
Medication Management (United States)
2018-2021
University of Minnesota
2021
University of Minnesota System
2019
University of Iowa
2013-2016
Texas Advanced Computing Center
2013
In 2014, the US Food and Drug Administration approved first glucagon-like peptide-1 (GLP-1) receptor agonist product, liraglutide injection, for obesity treatment. Many GLP-1 treatment clinical trials report significant weight loss medication adherence at more than 85%. Little is known about real-world adherence, persistence, switch rates.
BACKGROUND: Community pharmacists are well positioned to improve patient access care, which may assist value-based care programs in reaching patients. While pharmacy accessibility is broadly acknowledged, much of the research supporting claims poor quality. OBJECTIVE: To quantify comparison with physicians or qualified health professionals (QHP) a commercially insured population. METHODS: IBM MarketScan data from 2018 were used for this cross-sectional study. Beneficiaries included primary...
Pharmacy closures in rural areas is an increasingly common problem. Closures disrupt medication access and decrease adherence to prescription medications. Telepharmacy a potential solution this problem; however, research on the relationship between telepharmacy quality of use scarce. Our study sought address gap by comparing telepharmacies serving traditional pharmacies that support them.We obtained dispensing data for first 18 months operation from 3 located upper Midwest. We evaluated...
Despite increased use of continuous glucose monitoring (CGM) systems, studies to quantify patterns CGM are limited. In December 2018, a policy change by commercial insurer expanded coverage through the pharmacy benefit, creating an opportunity evaluate impact this on utilization.
Background Telehealth (telemedicine and telepharmacy) services increase access to patient ensure continuity of care. However, few studies have assessed factors that influence patients’ willingness use telehealth services, we sought investigate this. Objective This study aims examine respondents’ (aged between 45 75 years) (telepharmacy telemedicine) the correlates services. Methods We administered a cross-sectional national survey 1045 noninstitutionalized US adults aged years in March April...
As value-based and alternative payment models proliferate, there is growing interest in measuring pharmacy performance. However, little research has explored the development implementation of systems to measure Additionally, that currently exist rely on process surrogate outcome measures are not always relevant patients payers.This article describes used design implement a performance measurement program for group enhanced services pharmacies North Carolina. This was successful quality based...
Opioids and benzodiazepines (BZDs) are some of the most commonly prescribed medications that contribute to falls in older adults. These challenging appropriately prescribe monitor, with little guidance on safe prescribing these for patients. Only a handful small studies have evaluated whether reducing opioid BZD use through deprescribing has positive impact outcomes. Leveraging strengths large health system, we targeted consultant pharmacist intervention deprescribe opioids BZDs adults seen...
Importance Pharmacy deserts have increased, potentially affecting patient access and care. Historically, telepharmacies been used to reduce pharmacy restore access, but states frequently restrict their operation. Objective To analyze whether telepharmacy policy is associated with services. Design, Setting, Participants This cohort study analyzed location census data from 2016 through 2019 for US new policies. Nearby control were comparison in a pretest-posttest nonequivalent group design....
The National Quality Forum (NQF) evaluates healthcare performance measures for endorsement based on a broad set of criteria. We extracted data from NQF technical reports released between spring 2018 and 2019. Measures were commonly stewarded by federal agencies (44.29%), evaluated maintenance (67.14%), classified as outcome (42.14%) or process (39.29%) measures, used statistical model risk adjustment (48.57%). For 80% the reviewed, patient advocate was present reviewing committee. Validity...
Improving medication adherence can reduce health care spending, and studies have demonstrated community pharmacists positively affect through the provision of enhanced services. The North Carolina (NC) Community Pharmacy Enhanced Services Network (CPESN) was formed in early 2014 with goal enhancing provided its network pharmacies.
BACKGROUND: Community pharmacy participation in performance-based payment models has increased recent years. Despite this, there been neither much research done to evaluate the effect of these on health care quality and spending nor is extensive literature design models. OBJECTIVES: To (a) describe types measures used (PBPPMs); (b) financial impact PBPPMs pharmacies; (3) explore owners' perceptions PBPPMs; (4) any practice changes made response PBPPMs. METHODS: This a cross-sectional study...
BACKGROUND: In the United States, shift towards value-based health care seeks to improve patient outcomes while reducing spending. Although federal government has led implementation of performance-based models for physicians and systems, commercial entities have largely been responsible development similar within pharmacy. For purposes this study, pharmacy payment (PBPPMs) were defined as prescription drug that determine reimbursement or fees community pharmacies based in part on measured...
Patient-reported outcome measures (PROMs) that assess how patients feel and function have potential for evaluating quality of care. Stakeholder recommendations PRO-based performance (PMs) were elicited, feasibility testing was conducted at six cancer centers.